Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cinacalcet for Cardiovascular Events in Dialysis Patients
NCT00345839Phase 3Completed
- Sponsor
- Amgen
- Start
- Aug 2006
- Primary completion
- Apr 2012
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of cinacalcet in secondary hyperparathyroidism (SHPT), sponsored by Amgen. Started Aug 2006; status: completed.
02
Drugs
cinacalcet
03
Conditions
secondary hyperparathyroidism (SHPT)
Beyond the preview
Go deeper on NCT00345839.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00345839.